A cross-disciplinary University of Alberta research team has uncovered a biological marker for scleroderma that can predict which patients will develop severe disease and could also lead to new treatments.
Jan 9, 2024
0
1
Acute myeloid leukemia (AML) is a cancer type that originates in the bone marrow. Despite being considered a rare disease, it is the most common type of acute leukemia and progresses rapidly, necessitating immediate treatment.
Jan 5, 2024
0
0
Cedars-Sinai Cancer investigators have discovered a new way to predict whether a cancer of the immune system will recur in patients treated with a bone marrow transplant. Their study, published in the Journal of Clinical ...
Dec 21, 2023
0
0
For patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative conditioning regimen (NMAC) is feasible, ...
Dec 20, 2023
0
1
Across the United States, about 2 million people are living with an amputation and another 185,000 amputations occur every year, according to the Amputee Coalition, a Washington DC-based support group. About 54% of these ...
Dec 19, 2023
0
37
In a study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, patients recently diagnosed with a common and aggressive form of acute myeloid leukemia reported ...
Dec 11, 2023
0
0
Aging is associated with chronic, nonresolving inflammation, or "inflammaging," that can lead to tissue dysfunction. New findings reported in The American Journal of Pathology reveal insights into the cellular programs and ...
Dec 6, 2023
0
0
With the rapid development in computing power over the past few decades, machine-learning (ML) techniques have become popular in medical settings as a way to predict survival rates and life expectancies among patients diagnosed ...
Nov 20, 2023
0
0
Britain's medicines regulator has authorized the world's first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K.
Nov 16, 2023
0
1
Individuals living with severe sickle cell disease (SCD) are highly interested in new, potentially curative gene therapy treatments and are willing to accept associated risks for a chance at a cure, according to a study published ...
Oct 31, 2023
0
0
